Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of July 8, 2026, GKOS trades at $153.05 with a market cap of $8.85B and a P/E ratio of -46.62. GKOS moved +1.53% today. Year to date, GKOS is +35.47%; over the trailing twelve months it is +49.33%. Its 52-week range spans $73.16 to $163.71. Analyst consensus is strong buy with an average price target of $158.33. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for GKOS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $153.05 |
| Market Cap | $8.85B |
| P/E Ratio | -46.62 |
| EPS | $-3.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $163.71 |
| 52-Week Low | $73.16 |
| Volume | 844.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $507.44M |
| Net Income | $-187.69M |
| Gross Margin | 55.72% |
12 analysts cover GKOS: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $158.33.